维普期刊资源整合服务平台（V6.5）

180篇 您的检索式：作者名="HOFF PM"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Comparison of oral capecitabine versus intravenous fluorouraeil plus leueovofin as first-line treatment in 605 patients with metastatic colorectal cancer:results of a randomized phase Ⅲ study显示文摘	Hoff PM Amari R Batist G	2001	J Clin Oncol2001，19，8：	1
2	Role of angiogenesis in the path- ogenesis of cancer 显示文摘	HOFF PM MACHADO KK	2012	Cancer Treat Rev2012，38，7：	1
3	The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines,UFT/lecovorin (ORZEL) and S-l:a review of their clinical development and therapeutic potengtial显示文摘	Hoff PM	2000	Invest New Drugs2000，18，：	1
4	Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase Ⅲ study (HORIZON Ⅱ ) 显示文摘	Hoff PM Hochhaus A Pestalozzi BC	2012	J Clin Oncol2012，30，29：	1
5	Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first - line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase Ⅲ study 显示文摘	Hoff PM Ansari R Batist G	2001	J Clin Oncol2001，19，80：	1
6	Oral Capecitabine vs intravenous 5 -fluorouracil and leueovorin: integrated efficacy data and novel analyses from two large, randomised phase III trials显示文摘	Van Cutsem EV Hoff PM Harper P	2004	Br J Cancer2004，90，6：	1
7	Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase Ⅲ study 显示文摘	Hoff PM Ansari R Batist G	2001	J Clin Oncol2001，19，8：	1
8	Targeting the epidermal growth factor receptor:an important incremental step in the battle against colorectal cancer显示文摘	Ellis LM Hoff PM	2004	JClin Oncol2004，22，7：	1
9	The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomas 显示文摘	Fuchs CS	2003	Semin Oncol2003，30，：	1
10	Practical considerations in the use of oral fluoropyrimidines 显示文摘	Hoff PM	2003	Semin Oncol2003，30，：	1
11	Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer, results of a randomized phase Ⅲ study显示文摘	Hoff PM Ansari R Batist G	2001	J Clin Oncol2001，19，：	1
12	Bevacizumab : overview of the literature显示文摘	Braghiroli MI Sabbaga J Hoff PM	2012	Expert Review of Anticancer Therapy2012，12，5：	1
13	Phase I study with pharmaco- kinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors 显示文摘	Hoff PM Saad ED Ajani JA	2003	Clin Cancer Res2003，9，1：	1
14	Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma:report of a case显示文摘	Phan LK Hoff PM		0，，03：	1
15	Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors 显示文摘	Hoff PM Saad ED Ajani JA	2003	Clin Can Res2003，9，1：	1
16	Comparision of oral capecitabine versusintranenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancet:results of a randomized phase Ⅲ study显示文摘	Hoff PM Ansari R Batist G	2001	J Clin Oncol2001，19，8：	1
17	Case report:hand-foot syndrome induced by the oral fluoropyrimidine S-1显示文摘	Elasmar SA Saad ED Hoff PM	2001	Jpn Clin Onco2001，31，4：	1
18	Oral eapecitabinevs intravenous 5-fluorouracil and leueovorin : integrated efficacy data and novel analyses from two large, randomized, phase Ⅲ trials显示文摘	Van Cutsem E Hoff PM Harper P	2004	Br J Cancer2004，90，6：	1
19	Literature Review and Practical Aspects on the Management of Oxaliplat- in-Associated Toxicity显示文摘	Hoff PM Saad ED Costa F	2012	Clin Colorectal Cancer2012，11，2：	1
20	Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic coloreetal cancer: results of a randomized phase 1H study显示文摘	Hoff PM Ansari R Batist G ct al	2001	J Clin Oncol2001，19，8：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示